Literature DB >> 18353625

Cellular senescence in vivo: a barrier to tumorigenesis.

Alexandre Prieur1, Daniel S Peeper.   

Abstract

Cellular senescence is characterized by a largely irreversible cell cycle arrest that can be triggered by many types of intrinsic and extrinsic stress. These include telomere malfunction, oncogene activation and tumor suppressor gene inactivation. Ultimately, such events culminate in the activation of a tumor suppressor gene network. Since the first description of Oncogene-Induced cellular Senescence (OIS) little over a decade ago, many subsequent studies have confirmed that OIS prevents cells from undergoing oncogenic transformation in vitro. However, it has long been debated whether any in vivo correlates exist. It is only since recent years that evidence has been accumulating indicating that OIS in vivo does correspond to a major protective mechanism against cancer. In this review, we highlight some of the recent developments.

Entities:  

Mesh:

Year:  2008        PMID: 18353625     DOI: 10.1016/j.ceb.2008.01.007

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  115 in total

1.  TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression.

Authors:  Kyle Lafferty-Whyte; Alan Bilsland; Stacey F Hoare; Sharon Burns; Nadia Zaffaroni; Claire J Cairney; William Nicol Keith
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.

Authors:  Y Tang; I Horikawa; M Ajiro; A I Robles; K Fujita; A M Mondal; J K Stauffer; Z-M Zheng; C C Harris
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

3.  MicroRNA regulation of ionizing radiation-induced premature senescence.

Authors:  Yong Wang; Melissa N Scheiber; Carola Neumann; George A Calin; Daohong Zhou
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-17       Impact factor: 7.038

Review 4.  Histone methylation and aging: lessons learned from model systems.

Authors:  Brenna S McCauley; Weiwei Dang
Journal:  Biochim Biophys Acta       Date:  2014-05-21

5.  dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.

Authors:  Giulia Santinon; Irene Brian; Arianna Pocaterra; Patrizia Romani; Elisa Franzolin; Chiara Rampazzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2018-04-12       Impact factor: 11.598

6.  Telomere loss provokes multiple pathways to apoptosis and produces genomic instability in Drosophila melanogaster.

Authors:  Simon W A Titen; Kent G Golic
Journal:  Genetics       Date:  2008-10-09       Impact factor: 4.562

7.  Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.

Authors:  Jean-Philippe Coppé; Francis Rodier; Christopher K Patil; Adam Freund; Pierre-Yves Desprez; Judith Campisi
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

8.  p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.

Authors:  Adam Freund; Christopher K Patil; Judith Campisi
Journal:  EMBO J       Date:  2011-03-11       Impact factor: 11.598

9.  Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.

Authors:  Yan Liu; Fan Liu; Hao Yu; Xinyang Zhao; Goro Sashida; Anthony Deblasio; Michael Harr; Qing-Bai She; Zhenbang Chen; Hui-Kuan Lin; Silvana Di Giandomenico; Shannon E Elf; Youyang Yang; Yasuhiko Miyata; Gang Huang; Silvia Menendez; Ingo K Mellinghoff; Neal Rosen; Pier Paolo Pandolfi; Cyrus V Hedvat; Stephen D Nimer
Journal:  Sci Signal       Date:  2012-10-23       Impact factor: 8.192

Review 10.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.